2023 Q3 Form 10-Q Financial Statement
#000180116923000097 Filed on August 03, 2023
Income Statement
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| Revenue | $980.0M | $1.976B |
| YoY Change | -70.84% | -52.93% |
| Cost Of Revenue | $884.0M | $1.827B |
| YoY Change | -76.65% | -50.78% |
| Gross Profit | $96.00M | $149.0M |
| YoY Change | -122.59% | -69.34% |
| Gross Profit Margin | 9.8% | 7.54% |
| Selling, General & Admin | $133.0M | $168.0M |
| YoY Change | -61.45% | -59.32% |
| % of Gross Profit | 138.54% | 112.75% |
| Research & Development | $42.00M | $38.00M |
| YoY Change | 5.0% | -7.32% |
| % of Gross Profit | 43.75% | 25.5% |
| Depreciation & Amortization | $8.000M | $17.00M |
| YoY Change | -20.0% | 88.89% |
| % of Gross Profit | 8.33% | 11.41% |
| Operating Expenses | $175.0M | $206.0M |
| YoY Change | -54.55% | -54.63% |
| Operating Profit | -$79.00M | -$57.00M |
| YoY Change | -90.25% | -278.13% |
| Interest Expense | $47.00M | -$53.00M |
| YoY Change | -59.13% | -159.55% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $20.00M | $41.00M |
| YoY Change | -1100.0% | 925.0% |
| Pretax Income | -$106.0M | $24.00M |
| YoY Change | -88.57% | -145.28% |
| Income Tax | $0.00 | $1.000M |
| % Of Pretax Income | 4.17% | |
| Net Earnings | -$106.0M | $23.00M |
| YoY Change | -88.58% | -142.59% |
| Net Earnings / Revenue | -10.82% | 1.16% |
| Basic Earnings Per Share | -$0.16 | $0.04 |
| Diluted Earnings Per Share | -$0.16 | $0.03 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 659.2M shares | 648.8M shares |
| Diluted Shares Outstanding | 662.1M shares | 667.2M shares |
Balance Sheet
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.226B | $1.210B |
| YoY Change | -18.54% | -51.05% |
| Cash & Equivalents | $1.154B | $1.120B |
| Short-Term Investments | $72.00M | $90.00M |
| Other Short-Term Assets | $47.00M | $1.721B |
| YoY Change | -41.25% | 962.35% |
| Inventory | $1.311B | $1.149B |
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $3.819B | $4.093B |
| YoY Change | -60.15% | -58.84% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $68.00M | $90.00M |
| YoY Change | 9.68% | 66.67% |
| Goodwill | $4.000M | $4.000M |
| YoY Change | -93.55% | -93.33% |
| Intangibles | $7.000M | $9.000M |
| YoY Change | 0.0% | 28.57% |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $22.00M | $27.00M |
| YoY Change | -15.38% | 0.0% |
| Total Long-Term Assets | $128.0M | $130.0M |
| YoY Change | -36.0% | -31.94% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $3.819B | $4.093B |
| Total Long-Term Assets | $128.0M | $130.0M |
| Total Assets | $3.947B | $4.223B |
| YoY Change | -59.66% | -58.34% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $67.00M | $65.00M |
| YoY Change | -67.94% | -69.77% |
| Accrued Expenses | $7.000M | $8.000M |
| YoY Change | -65.0% | -52.94% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $0.00 | $15.00M |
| YoY Change | -100.0% | -99.56% |
| Total Short-Term Liabilities | $74.00M | $88.00M |
| YoY Change | -97.95% | -97.56% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $2.832B | $3.028B |
| YoY Change | -39.18% | -26.72% |
| Other Long-Term Liabilities | $1.000M | $21.00M |
| YoY Change | -97.44% | -50.0% |
| Total Long-Term Liabilities | $1.000M | $3.049B |
| YoY Change | -99.98% | -26.95% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $74.00M | $88.00M |
| Total Long-Term Liabilities | $1.000M | $3.049B |
| Total Liabilities | $2.927B | $3.137B |
| YoY Change | -64.72% | -59.68% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$3.242B | -$3.136B |
| YoY Change | 21.93% | 81.17% |
| Common Stock | $0.00 | $0.00 |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $1.020B | $1.086B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $3.947B | $4.223B |
| YoY Change | -59.66% | -58.34% |
Cashflow Statement
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$106.0M | $23.00M |
| YoY Change | -88.58% | -142.59% |
| Depreciation, Depletion And Amortization | $8.000M | $17.00M |
| YoY Change | -20.0% | 88.89% |
| Cash From Operating Activities | -$216.0M | $940.0M |
| YoY Change | -32.92% | -149.66% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $11.00M | $9.000M |
| YoY Change | -184.62% | -190.0% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $14.00M | $24.00M |
| YoY Change | -65.0% | -89.61% |
| Cash From Investing Activities | $3.000M | $15.00M |
| YoY Change | -88.89% | -93.21% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -213.0M | -809.0M |
| YoY Change | -140.96% | -145.71% |
| NET CHANGE | ||
| Cash From Operating Activities | -216.0M | 940.0M |
| Cash From Investing Activities | 3.000M | 15.00M |
| Cash From Financing Activities | -213.0M | -809.0M |
| Net Change In Cash | -426.0M | 146.0M |
| YoY Change | -289.33% | 48.98% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$216.0M | $940.0M |
| Capital Expenditures | $11.00M | $9.000M |
| Free Cash Flow | -$227.0M | $931.0M |
| YoY Change | -26.54% | -149.44% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense | ||
| us-gaap |
Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense | ||
| open |
Increase Decrease In Escrow Receivable
IncreaseDecreaseInEscrowReceivable
|
-17000000 | usd | |
| us-gaap |
Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
|
-3259000000 | usd | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
3000000 | usd | |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1000000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
0 | usd |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
25000000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1000000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
23000000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1086000000 | usd |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2000000 | usd | |
| us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1000000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
73000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
2000000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-78000000 | usd | |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1086000000 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2347000000 | usd |
| CY2022Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1000000 | usd |
| CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
63000000 | usd |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
134000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3000000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-26000000 | usd | |
| CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2356000000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-26000000 | usd | |
| us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
38000000 | usd | |
| us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
4000000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
126000000 | usd | |
| us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
1000000 | usd | |
| us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
0 | usd | |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
37000000 | usd | |
| us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
7000000 | usd | |
| open |
Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale
NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale
|
0 | usd | |
| open |
Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale
NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale
|
1000000 | usd | |
| us-gaap |
Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
|
0 | usd | |
| us-gaap |
Proceeds From Sale And Collection Of Loans Heldforsale
ProceedsFromSaleAndCollectionOfLoansHeldforsale
|
1000000 | usd | |
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
182000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-31000000 | usd | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-10000000 | usd | |
| open |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-6000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3102000000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
17000000 | usd | |
| us-gaap |
Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
|
0 | usd | |
| us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
1000000 | usd | |
| us-gaap |
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
45000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
183000000 | usd | |
| us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
270000000 | usd | |
| us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2000000 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
3000000 | usd | |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
1000000 | usd | |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
0 | usd | |
| us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
236000000 | usd | |
| us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
6608000000 | usd | |
| us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
2099000000 | usd | |
| us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
6162000000 | usd | |
| us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
0 | usd | |
| us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
105000000 | usd | |
| us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
0 | usd | |
| us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
100000000 | usd | |
| us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | usd | |
| us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
18000000 | usd | |
| us-gaap |
Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
|
4000000 | usd | |
| us-gaap |
Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2134000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
436000000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1013000000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
276000000 | usd | |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1791000000 | usd |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
126000000 | usd | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
145000000 | usd | |
| us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
10000000 | usd | |
| us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
8000000 | usd | |
| CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1120000000 | usd |
| CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2239000000 | usd |
| CY2023Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
1684000000 | usd |
| CY2022Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
615000000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2804000000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2854000000 | usd |
| CY2022Q2 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
| CY2022Q4 | open |
Equity Securities Fvni Cash And Cash Equivalents
EquitySecuritiesFVNICashAndCashEquivalents
|
0 | usd |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that have a material impact on the amounts reported in the financial statements and accompanying notes. Significant estimates, assumptions and judgments made by management include, among others, the determination of the fair value of common stock, share-based awards, and inventory valuation adjustment. Management believes that the estimates and judgments upon which management relies are reasonable based upon information available to management at the time that these estimates and judgments are made. To the extent there are material differences between these estimates, assumptions and judgments and actual results, the carrying values of the Company's assets and liabilities and the results of operations will be affected. The health of the residential housing market and interest rate environment have introduced additional uncertainty with respect to judgments, estimates and assumptions, which may materially impact the estimates previously listed, among others.</span></div> | ||
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, and investments in marketable securities. The Company places cash and cash equivalents and investments with major financial institutions, which management assesses to be of high credit quality, in order to limit exposure of the Company’s investments.</span></div> | ||
| CY2023Q2 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
1000000 | usd |
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
3000000 | usd | |
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd | |
| CY2023Q2 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
45000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
459000000 | usd |
| CY2023Q2 | us-gaap |
Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
|
252000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
|
891000000 | usd |
| CY2023Q2 | us-gaap |
Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
|
563000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
|
2788000000 | usd |
| CY2023Q2 | open |
Inventory Real Estate In Resale Contract
InventoryRealEstateInResaleContract
|
334000000 | usd |
| CY2022Q4 | open |
Inventory Real Estate In Resale Contract
InventoryRealEstateInResaleContract
|
781000000 | usd |
| CY2023Q2 | us-gaap |
Inventory Real Estate
InventoryRealEstate
|
1149000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Real Estate
InventoryRealEstate
|
4460000000 | usd |
| CY2023Q2 | us-gaap |
Recorded Unconditional Purchase Obligation Minimum Quantity Required
RecordedUnconditionalPurchaseObligationMinimumQuantityRequired
|
1390 | home |
| CY2023Q2 | us-gaap |
Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
|
469000000 | usd |
| CY2023Q2 | open |
Inventory Real Estate Valuation Adjustment Decrease Increase
InventoryRealEstateValuationAdjustmentDecreaseIncrease
|
14000000 | usd |
| open |
Inventory Real Estate Valuation Adjustment Decrease Increase
InventoryRealEstateValuationAdjustmentDecreaseIncrease
|
37000000 | usd | |
| CY2022Q2 | open |
Inventory Real Estate Valuation Adjustment Decrease Increase
InventoryRealEstateValuationAdjustmentDecreaseIncrease
|
82000000 | usd |
| open |
Inventory Real Estate Valuation Adjustment Decrease Increase
InventoryRealEstateValuationAdjustmentDecreaseIncrease
|
90000000 | usd | |
| CY2023Q2 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
18000000 | usd |
| CY2023Q2 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
18000000 | usd |
| CY2023Q2 | open |
Equity Securities Fvni Cash And Cash Equivalents
EquitySecuritiesFVNICashAndCashEquivalents
|
0 | usd |
| CY2023Q2 | open |
Equity Securities Fvni Marketable Securities
EquitySecuritiesFVNIMarketableSecurities
|
18000000 | usd |
| CY2023Q2 | open |
Cash Cash Equivalents And Marketable Securities Amortized Cost
CashCashEquivalentsAndMarketableSecuritiesAmortizedCost
|
1212000000 | usd |
| CY2023Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | usd |
| CY2023Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
2000000 | usd |
| CY2023Q2 | open |
Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
|
1210000000 | usd |
| CY2023Q2 | open |
Marketable Securities Cash And Cash Equivalents
MarketableSecuritiesCashAndCashEquivalents
|
1120000000 | usd |
| CY2023Q2 | us-gaap |
Marketable Securities
MarketableSecurities
|
90000000 | usd |
| CY2022Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
11000000 | usd |
| CY2022Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
11000000 | usd |
| CY2022Q4 | open |
Equity Securities Fvni Marketable Securities
EquitySecuritiesFVNIMarketableSecurities
|
11000000 | usd |
| CY2022Q4 | open |
Cash Cash Equivalents And Marketable Securities Amortized Cost
CashCashEquivalentsAndMarketableSecuritiesAmortizedCost
|
1285000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4000000 | usd |
| CY2022Q4 | open |
Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
|
1281000000 | usd |
| CY2022Q4 | open |
Marketable Securities Cash And Cash Equivalents
MarketableSecuritiesCashAndCashEquivalents
|
1137000000 | usd |
| CY2022Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
144000000 | usd |
| CY2023Q2 | us-gaap |
Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
|
6000000 | usd |
| us-gaap |
Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
|
7000000 | usd | |
| CY2022Q2 | us-gaap |
Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
|
-3000000 | usd |
| us-gaap |
Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
|
-25000000 | usd | |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
0 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
0 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
72000000 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
2000000 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
72000000 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
2000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
11000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
0 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
119000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
4000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
130000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
4000000 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | usd |
| CY2023Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
72000000 | usd |
| CY2023Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
65000000 | usd |
| CY2023Q2 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
7000000 | usd |
| CY2023Q2 | us-gaap |
Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
|
20000000 | usd |
| CY2022Q4 | us-gaap |
Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
|
20000000 | usd |
| CY2023Q2 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
5000000 | usd |
| CY2022Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
5000000 | usd |
| CY2023Q2 | us-gaap |
Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
|
25000000 | usd |
| CY2022Q4 | us-gaap |
Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
|
25000000 | usd |
| CY2023Q2 | us-gaap |
Other Restricted Assets
OtherRestrictedAssets
|
500000000 | usd |
| CY2022Q4 | us-gaap |
Other Restricted Assets
OtherRestrictedAssets
|
565000000 | usd |
| CY2021Q3 | open |
Option Indexed To Issuers Equity Cap Price Premium
OptionIndexedToIssuersEquityCapPricePremium
|
1 | |
| CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
146000000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
148000000 | usd |
| CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
84000000 | usd |
| CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
90000000 | usd |
| CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
62000000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
58000000 | usd |
| CY2023Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
9000000 | usd |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
19000000 | usd | |
| CY2022Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
9000000 | usd |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
18000000 | usd | |
| us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
0 | usd | |
| CY2022 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
4000000 | usd |
| us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd | |
| us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd | |
| CY2023Q2 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2022Q2 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
29000000 | usd |
| CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
20000000 | usd |
| CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
9000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
29000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
17000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
12000000 | usd |
| CY2023Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1000000 | usd |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3000000 | usd | |
| CY2022Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3000000 | usd |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5000000 | usd | |
| CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
4000000 | usd |
| CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
5000000 | usd |
| CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
9000000 | usd |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10712000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.13 | |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y6M | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1000000 | usd |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
2170000 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.05 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
331000 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
2.91 | ||
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
8211000 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.39 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y8M12D | ||
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
14000000 | usd |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
8211000 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.39 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y8M12D | ||
| CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
14000000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
21000000 | usd |
| CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
59000000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
63000000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
126000000 | usd | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000000 | usd | |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0077 | ||
| CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000000 | usd |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000000 | usd | |
| CY2022Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0152 | |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0422 | ||
| CY2023Q2 | us-gaap |
Dividends
Dividends
|
0 | usd |
| CY2022Q2 | us-gaap |
Dividends
Dividends
|
0 | usd |
| us-gaap |
Dividends
Dividends
|
0 | usd | |
| us-gaap |
Dividends
Dividends
|
0 | usd | |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
23000000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-54000000 | usd |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-26000000 | usd | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
646062000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
646750000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
622064000 | shares | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.04 | |
| CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.12 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | ||
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
23000000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-54000000 | usd |
| us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-78000000 | usd | |
| us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-26000000 | usd | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
646062000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
624958000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
646750000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
622064000 | shares | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
667159000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
624958000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
646750000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
622064000 | shares | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.12 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | ||
| CY2022Q2 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | usd |
| CY2023Q2 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | usd |
| us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | usd | |
| us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | usd | |
| CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
30577000 | shares |
| CY2022Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
70778000 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
80603000 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
70778000 | shares | |
| CY2023Q2 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
|
560 | employee |
| CY2023Q2 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
|
0.22 | |
| CY2023Q2 | us-gaap |
Severance Costs1
SeveranceCosts1
|
10000000 | usd |
| CY2022Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
4000000 | usd |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
10000000 | usd | |
| us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
13000000 | usd | |
| CY2023Q2 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
1000000 | usd |
| CY2023Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
| CY2023Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
| CY2023Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false |
